Your browser doesn't support javascript.
loading
Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis.
Brown, Jennifer R; Moslehi, Javid; Ewer, Michael S; O'Brien, Susan M; Ghia, Paolo; Cymbalista, Florence; Shanafelt, Tait D; Fraser, Graeme; Rule, Simon; Coutre, Steven E; Dilhuydy, Marie-Sarah; Cramer, Paula; Jaeger, Ulrich; Dreyling, Martin; Byrd, John C; Treon, Steven; Liu, Emily Y; Chang, Stephen; Bista, Amulya; Vempati, Rama; Boornazian, Lisa; Valentino, Rudolph; Reddy, Vijay; Mahler, Michelle; Yang, Huiying; Graef, Thorsten; Burger, Jan A.
Afiliación
  • Brown JR; Chronic Lymphocytic Leukemia Center, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Moslehi J; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
  • Ewer MS; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • O'Brien SM; Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, CA, USA.
  • Ghia P; Strategic Research Program on CLL, Università Vita-Salute San Raffaele Milano and IRCCS Istituto Scientifico San Raffaele, Milan, Italy.
  • Cymbalista F; Hôpital Avicenne, Paris, France.
  • Shanafelt TD; Mayo Clinic, Rochester, MN, USA.
  • Fraser G; Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada.
  • Rule S; Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, UK.
  • Coutre SE; Stanford University School of Medicine, Stanford, CA, USA.
  • Dilhuydy MS; CHU Hopitaux de Bordeaux, Pessac, France.
  • Cramer P; German CLL Study Group, University of Cologne, Cologne, Germany.
  • Jaeger U; Medical University of Vienna, Wien, Austria.
  • Dreyling M; University Hospital LMU Munich, Munich, Germany.
  • Byrd JC; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Treon S; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Liu EY; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA.
  • Chang S; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA.
  • Bista A; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA.
  • Vempati R; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA.
  • Boornazian L; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA.
  • Valentino R; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA.
  • Reddy V; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA.
  • Mahler M; Janssen Research & Development, LLC, Raritan, NJ, USA.
  • Yang H; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA.
  • Graef T; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA.
  • Burger JA; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Br J Haematol ; 184(4): 558-569, 2019 02.
Article en En | MEDLINE | ID: mdl-30506764
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazoles / Pirimidinas / Hemorragia Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazoles / Pirimidinas / Hemorragia Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos